Abstract:Purpose: Despite the diagnostic and etiological significance of in-patient MRI in ischemic stroke (IS), its utilization is considered resource-intensive, expensive, and thus limiting feasibility and relevance. This study investigated the utilization of in-patient MRI for IS patients and its impact on patient and healthcare resource utilization outcomes. Methods: This retrospective registry-based study analyzed 1,956 IS patients admitted to Halifax's QEII Health Centre between 2015 and 2019. Firstly, temporal trends of MRI and other neuroimaging utilization were evaluated. Secondly, we categorized the cohort into two groups (MRI vs. No MRI; in addition to a non-contrast CT) and investigated adjusted differences in patient outcomes at admission, discharge, and post-discharge using logistic regression. Additionally, we analyzed healthcare resource utilization using Poisson log-linear regression. Furthermore, patient outcomes significantly associated with MRI use underwent subgroup analysis for stroke severity (mild stroke including transient ischemic attack vs. moderate and severe stroke) and any acute stage treatment (thrombolytic or thrombectomy or both vs. no treatment) subgroups, while using an age and sex-adjusted logistic regression model. Results: MRI was used in 40.5% patients; non-contrast CT in 99.3%, CT angiogram in 61.8%, and CT perfusion in 50.3%. Higher MRI utilization was associated with male sex, younger age, mild stroke, wake-up stroke, and no thrombolytic or thrombectomy treatment. MRI use was independently associated with lower in-hospital mortality (adjusted OR, 0.23; 95% CI, 0.15–0.36), lower symptomatic neurological status changes (0.64; 0.43–0.94), higher home discharge (1.32; 1.07–1.63), good functional outcomes at discharge (mRS score 0–2) (1.38; 1.11–1.72), lower 30-day stroke re-admission rates (0.48; 0.26–0.89), shorter hospital stays (regression coefficient, 0.92; 95% CI, 0.90–0.94), and reduced direct costs of hospitalization (0.90; 0.89–0.91). Subgroup analysis revealed significantly positive association of MRI use with most patient outcomes in moderate and severe strokes subgroup and non-acutely treated subgroup. Conversely, outcomes in mild strokes (including TIAs) subgroup and acute treatment subgroup were comparable regardless of MRI use. Conclusion: A substantial proportion of admitted IS patients underwent MRI, and MRI use was associated with improved patient outcomes and reduced healthcare resource utilization. Considering the multifactorial nature of IS patient outcomes, further randomized controlled trials are suggested to investigate the role of increased MRI utilization in optimizing in-patient IS management.

MRI utilization during the diagnostic and post-diagnostic phases in multiple sclerosis.

Correlation between MRI utilization and therapy switches in disease-modifying treatments for multiple sclerosis

Exploring the role of in-patient magnetic resonance imaging use among admitted ischemic stroke patients in improving patient outcomes and reducing healthcare resource utilization

Emerging Perspectives on MRI Application in Multiple Sclerosis: Moving from Pathophysiology to Clinical Practice

MRI Prognostic Factors in Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Antibody Disease

Advances in brain imaging in multiple sclerosis

Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis

The Role of Advanced Magnetic Resonance Imaging Sequences in Multiple Sclerosis

Advanced MRI Techniques: Diagnosis and Follow-Up of Multiple Sclerosis

Trends in magnetic resonance and computed tomography angiography utilization among Medicare beneficiaries between 2013 and 2020

An Algorithm to Predict the Need for Magnetic Resonance Imaging to Support Disease Monitoring in Multiple Sclerosis

Using quantitative MRI to track cerebral damage in multiple sclerosis: a longitudinal study

Clinical implications of increased use of MRI in TIA

Lifestyle management and brain MRI metrics in female Australian adults living with multiple sclerosis: a feasibility and acceptability study

An update on the role of magnetic resonance imaging in predicting and monitoring multiple sclerosis progression

The use of 7T MRI in multiple sclerosis: review and consensus statement from the North American Imaging in Multiple Sclerosis Cooperative

Clinical Diagnosis and Magnetic Resonance Imaging in Patients With Transient and Minor Neurological Symptoms: A Prospective Cohort Study.

Impact of Early MRI in Ischemic Strokes Beyond Hyper-acute Stage to Improve Patient Outcomes, Enable Early Discharge, and Realize Cost Savings

Magnetic Resonance Imaging Utilization in an Emergency Department Observation Unit

A Comparison of Magnetic Resonance Imaging Methods to Assess Multiple Sclerosis Lesions: Implications for Patient Characterization and Clinical Trial Design

Disparities in the Utilization of MRI for Prostate Cancer Detection: A Population-Based Study